SLC35F5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.746200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.787400E-01
Normal-vs-Stage2
4.147200E-01
Normal-vs-Stage3
6.166200E-01
Normal-vs-Stage4
2.806200E-01
Stage1-vs-Stage2
9.322000E-01
Stage1-vs-Stage3
1.649010E-01
Stage1-vs-Stage4
4.396400E-01
Stage2-vs-Stage3
1.471580E-01
Stage2-vs-Stage4
3.651200E-01
Stage3-vs-Stage4
9.274100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.896000E-01
Normal-vs-AfricanAmerican
3.890800E-01
Normal-vs-Asian
7.281200E-01
Caucasian-vs-AfricanAmerican
5.939800E-01
Caucasian-vs-Asian
5.386000E-01
AfricanAmerican-vs-Asian
4.064200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.787000E-01
Normal-vs-Female
4.647200E-01
Male-vs-Female
6.594600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.897200E-01
Normal-vs-Age(41-60Yrs)
2.935600E-01
Normal-vs-Age(61-80Yrs)
5.574200E-01
Normal-vs-Age(81-100Yrs)
8.516800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.624000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.191800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.792600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.192100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.014430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.600400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.386400E-01
Normal-vs-Daily Drinker
9.543000E-01
Normal-vs-Weekly Drinker
5.131800E-01
Normal-vs-Occasional Drinker
3.922000E-01
Normal-vs-Social Drinker
3.566600E-01
Non Drinker-vs-Daily Drinker
2.751200E-01
Non Drinker-vs-Weekly Drinker
4.655800E-01
Non Drinker-vs-Occasional Drinker
1.871760E-01
Non Drinker-vs-Social Drinker
2.122000E-01
Daily Drinker-vs-Weekly Drinker
1.573760E-01
Daily Drinker-vs-Occasional Drinker
5.330000E-02
Daily Drinker-vs-Social Drinker
5.735600E-02
Weekly Drinker-vs-Occasional Drinker
6.805200E-01
Weekly Drinker-vs-Social Drinker
7.292800E-01
Occasional Drinker-vs-Social Drinker
9.331600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.313180E-01
Normal-vs-Grade 2
2.828100E-02
Normal-vs-Grade 3
1.218380E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.746400E-02
Grade 1-vs-Grade 3
4.180700E-03
Grade 1-vs-Grade 4
1.313180E-01
Grade 2-vs-Grade 3
1.777760E-01
Grade 2-vs-Grade 4
2.828100E-02
Grade 3-vs-Grade 4
1.218380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.646800E-01
Normal-vs-NonDiabetic
4.925200E-01
Diabetic-vs-NonDiabetic
6.202600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.755000E-01
Normal-vs-NoPancreatitis
4.961800E-01
Pancreatitis-vs-NoPancreatitis
1.934600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.243200E-01
Normal-vs-N1
3.917800E-01
N0-vs-N1
2.534600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.052000E-01
Normal-vs-TP53-NonMutant
7.270400E-01
TP53-Mutant-vs-TP53-NonMutant
1.672030E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
